T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Discretionary | 15.13% |
| 3 | Financials | 13.68% |
| 4 | Technology | 12.92% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Helmerich & Payne
HP
$4.43B
| $11.8M | ﹤0.01% |
201,000
+160
| +0.1% | +$8.46K |
|
1227
Generac Holdings
GNRC
$13B
| $11.7M | ﹤0.01% |
314,765
+10,550
| +3% | +$340K |
|
1228
Ardelyx
ARDX
$1.02B
| $11.7M | ﹤0.01% |
1,508,115
+1,497,010
| +13,481% | +$14.7M |
|
1229
H&R Block
HRB
$6.72B
| $11.7M | ﹤0.01% |
443,418
+2,380
| +0.5% | +$74.8K |
|
|
AXON
1230
Axon Enterprise
AXON
$49.3B
| $11.7M | ﹤0.01% |
594,450
+14,116
| +2% | +$242K |
|
|
TE
1231
DELISTED
TECO ENERGY INC
TE
| $11.6M | ﹤0.01% |
420,385
-3,000
| -0.7% | -$81.8K |
|
|
ACAT
1232
DELISTED
Arctic Cat Inc
ACAT
| $11.6M | ﹤0.01% |
688,105
+110,150
| +19% | +$1.66M |
|
|
CRZO
1233
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $11.5M | ﹤0.01% |
372,050
+28,600
| +8% | +$721K |
|
|
POLY
1234
DELISTED
Plantronics, Inc.
POLY
| $11.5M | ﹤0.01% |
292,970
+56,930
| +24% | +$2.23M |
|
1235
Oneok
OKE
$59.5B
| $11.4M | ﹤0.01% |
383,170
+500
| +0.1% | +$12.3K |
|
1236
Qorvo
QRVO
$8.68B
| $11.4M | ﹤0.01% |
226,590
-28,230
| -11% | -$1.23M |
|
|
SHOR
1237
DELISTED
ShoreTel, Inc.
SHOR
| $11.4M | ﹤0.01% |
1,529,482
-296,800
| -16% | -$2.26M |
|
1238
Galicia Financial Group
GGAL
$7.06B
| $11.3M | ﹤0.01% |
399,160
+130,380
| +49% | +$3.61M |
|
|
CLNY
1239
DELISTED
Colony Capital, Inc.
CLNY
| $11.3M | ﹤0.01% |
673,290
-2,050
| -0.3% | -$34.4K |
|
|
AFFX
1240
DELISTED
Affymetrix Inc
AFFX
| $11.1M | ﹤0.01% |
794,200
-80,000
| -9% | -$1.1M |
|
1241
Globe Life
GL
$14.1B
| $11.1M | ﹤0.01% |
205,406
-210
| -0.1% | -$11.2K |
|
|
INST
1242
DELISTED
Instructure, Inc.
INST
| $11.1M | ﹤0.01% |
617,070
+1,100
| +0.2% | +$18.9K |
|
1243
Phibro Animal Health
PAHC
$1.4B
| $10.9M | ﹤0.01% |
404,780
+2,940
| +0.7% | +$84.3K |
|
|
BLOX
1244
DELISTED
Infoblox Inc
BLOX
| $10.9M | ﹤0.01% |
635,720
+2,060
| +0.3% | +$32.9K |
|
|
SNI
1245
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $10.7M | ﹤0.01% |
164,090
+430
| +0.3% | +$25.6K |
|
1246
Ralph Lauren
RL
$23.1B
| $10.7M | ﹤0.01% |
110,925
+695
| +0.6% | +$68.1K |
|
|
BLCM
1247
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $10.7M | ﹤0.01% |
114,144
-3,205
| -3% | -$349K |
|
1248
Williams-Sonoma
WSM
$28.6B
| $10.6M | ﹤0.01% |
386,332
+50,762
| +15% | +$1.38M |
|
1249
Regenxbio
RGNX
$685M
| $10.6M | ﹤0.01% |
976,933
+4,000
| +0.4% | +$51.2K |
|
1250
Apogee Enterprises
APOG
$877M
| $10.4M | ﹤0.01% |
237,370
-116,430
| -33% | -$4.62M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.